With more than 50 manufacturing facilities across six continents, Baxter’s global presence provides opportunities for unique manufacturing collaborations to provide the most value for our partners. The power of an extensive global network lies in the coordination of, and efficiencies resulting from, a systemic approach to cGMP manufacturing.

More Content From Baxter BioPharma Solutions

Experience Makes the Difference
Optimizing lyophilization cycle times and improving stability for complex injectables is a critical component of parenteral product development. With this understanding, BioPharma Solutions established the Lyophiliz…

Baxter has been honored to be recognized globally with various awards and distinctions by the industry, as well as by sustainability, community support and environmental organizations. Download the attached for a sampling, with a full list available…

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose, in the native secondary and tertiary structure, without unintended chemical modifications, and fre…

Formulation, process, and analytical development for antibody - drug conjugates, or ADCs, is complex. While the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path a…

Assurance of the vacuum integrity of freeze - dryers used for the manufacture of sterile pharmaceutical products is essential for GMP operations; however, there is currently no generally accepted scientific rationale for establishing acceptance crite…

Applying LEAN techniques can result in improved productivity, workflow efficiency and cost savings. The Quality Control Laboratory at Baxter’s contract manufacturing facility in Halle/Westfalen, Germany, has been applying LEAN techniques since…

Management of medication delivery through lyophilization - freeze-drying - is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins and monoclonal antibodies, must b…

Baxter's BioPharma Solutions contract manufacturing business was recently recognized for the fourth time as Best Contract Manufacturing Organization at the annual Vaccine Industry Excellence (ViE) Awards, held at the World Vaccine Congress in…